Medically reviewed by Dr. Tino Katsande, MB ChB — 01 June 2025
🔄Last reviewed: June 2025

Let me tell you something that took me years of clinical practice to say clearly to patients: hypertension in Black and African patients is not the same condition as hypertension in white patients. Same name. Same numbers on the blood pressure cuff. Different disease — different causes, different severity, different response to medication.

I say this not to alarm you but because understanding this difference is genuinely useful.

ℹ️
The numbers that matter
Normal blood pressure is below 120/80 mmHg. Hypertension is diagnosed at 140/90 mmHg or above. The top number (systolic) is your heart contracting. The bottom (diastolic) is your heart at rest.

The disparity is real and well-documented

The evidence is substantial and consistent across decades of research:

  • Black adults in the UK develop hypertension approximately 10 years earlier than white adults
  • Around 40% of Black British adults have hypertension, versus 30% of the general population
  • Hypertension in Black patients is more severe at diagnosis — higher pressures, more organ damage already present
  • Rates of stroke, kidney disease, and heart failure from hypertension are significantly higher
UK statistics at a glance
~40%
Black British adults with hypertension
10 yrs
Earlier onset vs white adults
2–4×
Higher stroke risk if uncontrolled

Why standard first-line medication often works less well

This is the clinical fact every Black patient with hypertension deserves to know.

Standard first-line treatment — ACE inhibitors (ramipril, lisinopril) — works by blocking the renin-angiotensin system. Black patients tend to have lower renin levels, making this mechanism less effective. NICE guidelines now explicitly acknowledge this.

NICE guidance states: "For people of black African or African-Caribbean family origin, offer a calcium channel blocker as the first choice for initial treatment." — NICE NG136 (2023)

Calcium channel blockers (amlodipine is the most common) work through a different mechanism and tend to be more effective. If you are Black and currently on an ACE inhibitor alone with poorly controlled blood pressure, this is worth discussing with your GP.

Case study: Chipo's experience

Chipo, 48, a teacher from Zimbabwe based in Birmingham, was diagnosed with hypertension at 43. Her GP prescribed ramipril. Six months later her pressure remained at 158/96. The dose was increased. It stayed high.

After reading about the NICE guidance, she asked her GP about switching to amlodipine. Her GP agreed immediately and made the switch. Three months later: 132/82. Well controlled ever since.

"My doctor didn't volunteer the information. Once I asked, he immediately agreed." This is not a criticism — GP appointments are 10 minutes and guidance isn't always top of mind. But informed patients get better outcomes.

⚠️
Do not stop medication without speaking to your doctor
Uncontrolled hypertension carries serious risks. This article is to inform a conversation with your doctor, not replace it.

The salt question

Salt sensitivity is genuinely relevant. Research shows sodium reduction has a larger blood pressure-lowering effect in Black patients than in white patients. UK guidelines recommend less than 6g of salt daily. The biggest sources are not what you add at the table — they are processed foods, bread, stock cubes, and seasoning mixes.

Home blood pressure monitoring

I recommend home monitoring for all hypertension patients — but especially Black patients. Sit quietly for 5 minutes, measure twice on the same arm, record both. A reliable monitor (Omron, Microlife) costs £25–50 and gives your doctor far more information than a single clinic reading.

When to call 999

  • Sudden severe headache unlike any before
  • Sudden vision changes or loss
  • Chest pain
  • Sudden weakness or numbness in face, arm, or leg
  • Blood pressure above 180/120 with any symptoms

Sources: NICE NG136 (2023); British Heart Foundation Ethnicity Statistics 2023; Victor RG et al, NEJM 2004; Cappuccio FP, Journal of Human Hypertension 2018.

TK
Dr. Tino Katsande, MB ChB
General Practitioner · NHS · London, UK

Dr. Tino Katsande is a Zimbabwe-born General Practitioner working within the NHS in London. With over a decade of clinical experience across primary care and community health, he writes to bridge the gap between clinical medicine and what patients actually need to know. His particular interest is in conditions that disproportionately affect Black and African patients — including hypertension, diabetes, sickle cell, and mental health — which remain underrepresented in mainstream health media.

⚠️
Medical disclaimer
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional about any health concerns. In an emergency, call 999 (UK) or your local emergency number immediately. See our full medical disclaimer.